Nyhet -

Partnering with SDS MedteQ and SDS Life Science is a good idea

Understanding complex regulatory business, quality assurance, setting strategy, preparing clinical studies, establishing synopsis and end points, collecting patient data, and so on – companies in both medical technology and pharmaceutical drug development have many parameters to conform to.

Sister companies SDS MedteQ and SDS Life Science provides expertise in the extensive areas of regulatory affairs and quality assurance to developers of medical technology products, pharmaceutical drugs, and combination products.

“We have unique knowledge within the company and can make a big difference for our customers and their projects. We can deliver indispensable expertise, especially in complex projects where the development concerns advanced combination products, or products that belong in the borderland of medical technology and pharmaceutical drug development. For such products, we are unique as a consultancy with the extent of knowledge within both pharma and medtech”, says Anna-Karin Alm, Managing Director SDS MedteQ.

The SDS team has expanded over the last couple of years and consists of over 80 experts in all areas related to the development of medical devices, IVD’s, pharmaceuticals and combination products.

The new challenge

In the spring of 2021, a major change took place in the regulatory framework for medical devices. The revised MDR clarifies the standard for clinical trials, increasing the demand of clinical data to be provided. This is to prove the safety and performance of the products for patients.

The introduction of the new MDR regulatory has brought new challenges for companies with existing products on the market or with products that were about to be launched before the regulations.

Many medical technology companies, and especially smaller companies, lack the competence to be able to perform clinical trials to the level required by the new MDR. It is difficult for any individual company to keep track of all regulations.

Making a difference

SDS MedteQ and SDS Life Science are involved as strategic partners throughout the entire regulatory process – from initial development to market launch of new medical devices and pharmaceuticals.

“The new regulations within MDR are a challenge for most medical technology developers, but hope lies in partnering up with external teams that possess the necessary expertise when it comes to clinical project management”, says Anna-Karin Alm.

“We often partner up with smaller companies but do not exclude collaboration with larger companies”, she continues.

In conclusion, Anna-Karin Alm sums up the key advantages of working with SDS MedteQ and SDS Life Science:

“We have the expertise and resources to work with the most innovative developers in medical technology as well as pharmaceutical drug development and combination products. Being comprehensive is our main strength. We provide support for our clients to get to the next level. We also see a strong growth potential, both for us and for our customers, thanks to the introduction of MDR. Here, we can really make a difference”.

Relaterade länkar

Ämnen

  • Ekonomi, finans

Kategorier

  • gothenburg life science

Regioner

  • Västra Götaland

Kontakter

Relaterad media

Relaterat innehåll

  • Key2Compliance excels in QA Services

    Key2Compliance can help companies in the pharmaceutical, medical device and in vitro diagnostic industry to avoid the pitfalls that regulatory requirements may present. With a strong offer in Quality Assurance, Key2Compliance can help clients reach the next level – all the way from development to commercial phase.
    For individual innovators or SMEs, it can be difficult to keep track of the regul

  • Internet of Things gives personalised incontinence care

    The world is changing and the demand for innovative hygiene and health products is increasing at a high speed. Pressure on healthcare funding and staff, the acceleration of home care and an increasing importance of sustainability consumerization are three major trends within the health and medical area looking into the future.
    Essity, who is the leading global player in incontinence products wi

  • PharmaRelations: mapping out what Life Science companies need to grow

    Closely followed by successful establishment in Medicon Village in Lund, PharmaRelations is now setting up business at Sahlgrenska Science Park in Gothenburg. This is all part of the long-term strategy; to successfully combines Nordic coverage with local expertise within all areas of Life Science.
    The core idea of all operations at PharmaRelations is to guide and support companies in Life Scien

  • Nanofluidic scattering microscopy can accelerate the Life Science industry

    A company that is operating at the absolute forefront of technology is the award-winning Envue Technologies. The company is a spin-out based on academic research from Chalmers University of Technology, residing at the Chalmers Ventures Incubator.
    Three researchers in physics have developed a new and completely ground-breaking microscopy-based technology, the so-called nanofluidic scattering mi

  • TATAA Biocenter to offer GLP services to developers of cell and gene therapies across the world

    TATAA Biocenter was first to develop PCR technology in Sweden and was also a pioneer by offering covid tests at the very beginning of the outbreak of the pandemic. TATAA Biocenter is now building Europe’s most modern laboratory for molecular analyses in Gothenburg.
    The team behind TATAA Biocenter has worked with molecular analyses for over 30 years. The company was established around 20 years a

Fyll i din epostadress för att följa Affärstidningen Näringsliv

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Affärstidningen Näringsliv.

Okej